Natraj Proteins Reports Significant Loss in Q2 FY26 Amid Revenue Decline
Natraj Proteins Limited, operating in solvent extraction and commodities derivative trading, reported a substantial loss for Q2 FY26. The company's net loss stood at ₹286.46 crore, compared to a profit of ₹101.48 crore in Q2 FY25, marking a 382.28% decline. Revenue slightly decreased by 1.35% to ₹2655.74 crore. Earnings per share (EPS) fell to -₹7.65 from ₹2.71 in the previous year. The company did not provide segment-wise performance details due to sales from commodities derivatives falling below reporting thresholds.
*this image is generated using AI for illustrative purposes only.
Natraj Proteins Limited , a company operating in the solvent extraction and commodities derivative trading segments, has reported a substantial loss for the second quarter of the fiscal year 2026. The company's financial performance shows a marked deterioration compared to the same period last year.
Financial Highlights
| Particulars | Q2 FY26 | Q2 FY25 | Change |
|---|---|---|---|
| Revenue | ₹2655.74 crore | ₹2692.17 crore | -1.35% |
| Net Profit/(Loss) | (₹286.46 crore) | ₹101.48 crore | -382.28% |
| EPS | (₹7.65) | ₹2.71 | -382.28% |
Natraj Proteins Limited experienced a significant downturn in its financial performance for the quarter ended September 30, 2025. The company reported a net loss of ₹286.46 crore, a stark contrast to the profit of ₹101.48 crore recorded in the same quarter of the previous year. This represents a substantial decline of 382.28% in the company's bottom line.
Revenue and Operational Performance
The company's revenue from operations saw a marginal decrease of 1.35%, falling to ₹2655.74 crore from ₹2692.17 crore in the corresponding quarter of the previous year. This slight decline in revenue, coupled with increased expenses, contributed to the significant loss reported by the company.
Earnings Per Share
The earnings per share (EPS) for the quarter plummeted to negative ₹7.65, down from a positive ₹2.71 in the same quarter of the previous year. This sharp decline in EPS reflects the substantial impact of the loss on shareholder value.
Segment Performance
Natraj Proteins operates in two primary segments: solvent extraction and commodities derivative trading. However, the company's financial report does not provide a detailed breakdown of segment-wise performance, as the sales from commodities derivatives were below the threshold limits for segmental reporting.
Conclusion
The dramatic shift from profit to loss in just one year raises questions about the factors contributing to this decline. As Natraj Proteins navigates through this difficult period, stakeholders will likely keep a close watch on the company's future financial reports and any strategic initiatives announced to improve its financial health and operational performance.
Historical Stock Returns for Natraj Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.56% | -1.78% | -3.52% | -4.20% | -14.07% | +100.63% |
16
